One of the most successful candidate HIV vaccines to date - initially tested in Thailand, where it had modest effects - showed surprisingly strong efficacy when evaluated in a South African cohort, where a different strain of HIV is known to circulate. The research hints the RV144 vaccine regimen could provide protection against multiple strains of HIV, whose genetic diversity is a challenge for vaccine strategies.
Scientists have attempted to create a vaccine for HIV that can provide long-lasting protection, but most candidates have failed to provide substantial benefits in early clinical trials. The RV144 vaccine granted modest protection against the clade B HIV subtype in a clinical trial in Thailand. However, it is unclear whether RV144 could provide benefits to people living in regions such as South Africa that are dominated by different clades of the virus.
To investigate, researchers compared immunological data from the RV144 study to an analysis of 100 HIV-negative South Africans who were given the same vaccine in a phase 1b trial. Surprisingly, they discovered that the RV144 regimen stimulated even stronger immune responses in the South Africans while being well-tolerated.
Specifically, the vaccine elicited CD4+ T cell and anti-HIV antibody responses that are associated with protection against HIV, irrespective of sex, age or locale. The authors also observed that immune responses waned over time in both studies, suggesting that additional booster doses could help maintain the vaccine's efficacy.
More research is needed to see if the vaccine grants protection from infection, but the findings indicate that RV144 could be more adaptable across endemic regions than previously thought.
https://stm.sciencemag.org/content/11/510/eaax1880
Latest News
Men with gene mutations are…
By newseditor
Posted 17 May
B cell oxidative phosphoryl…
By newseditor
Posted 17 May
Human brain gene therapy us…
By newseditor
Posted 16 May
Small-molecular mimic of a…
By newseditor
Posted 16 May
Centromere structure and ch…
By newseditor
Posted 16 May
Other Top Stories
Drug used to treat cancer appears to sharpen memory
Read more
Preventing Parkinson's neuronal death by controlling mitochondrial…
Read more
Transcriptional silencing in Fragile X syndrome
Read more
Unexpected link between choroid plexus and chronic pain
Read more
Novel signature in the brains of children with cerebral malaria
Read more
Protocols
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Methods for making and obse…
By newseditor
Posted 15 May
Mime-seq 2.0: a method to s…
By newseditor
Posted 13 May
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Publications
Obesity-induced blood-brain…
By newseditor
Posted 18 May
CRISPR/Cas9 model of prosta…
By newseditor
Posted 17 May
Modulation of host immunity…
By newseditor
Posted 17 May
Variability in cell divisio…
By newseditor
Posted 17 May
Biallelic BORCS8 variants c…
By newseditor
Posted 17 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar